English
简体中文
Total: £ 56.28
Published Date: 2025-09-18 | Pages: 103 | Tables: 108 | Medical Care
The global Liposome Development Service market size was US$ 1217 million in 2024 and is forecast to a readjusted size of US$ 2079 million by 2031 with a CAGR of 8.1% during the forecast period 2025-2031.
Liposomes are a type of nano-sized phospholipid bubbles, which have attracted much attention as potential drug carriers. Liposomes are highly biocompatible and easy to control in vivo and can be loaded with a broad variety of drugs, DNA, and diagnostic agents. To date, a variety of liposomal drugs are under development and some of them are already approved for clinical use.
Market Driver
The liposome development service market is driven by the growing demand for advanced drug delivery systems that enhance the bioavailability, efficacy, and safety of therapeutics. Liposomes, being biocompatible and capable of targeted drug delivery, are increasingly used in the development of treatments for cancer, infectious diseases, and vaccines. Additionally, the rise in biologics and personalized medicine, coupled with advancements in nanotechnology, supports the growth of the liposome development service market.
Market Challenge
Despite its potential, the liposome development service market faces challenges such as high production costs and complex manufacturing processes that require specialized expertise and facilities. Regulatory hurdles in the approval of liposome-based therapies and the potential for stability issues during storage and transportation further constrain the market's growth. These factors create barriers, particularly for smaller companies with limited resources.
Global key players of liposome development service include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, etc. The top two players hold a share over 52%. North America is the largest market, has a share about 61%, followed by Europe and Asia-Pacific, with share 26% and 11%, separately. In terms of product type, Lipid Nanoparticles is the largest segment, occupied for a share of 62%, and in terms of application, Commercial has a share about 86 percent.
The global Liposome Development Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics
Creative Biolabs
Creative Biostructure
T&T Scientific
FormuMax Scientific
PlantaCorp
CD Bioparticles
By Type: (Dominant Segment vs High-Margin Innovation)
Liposomes
Lipid Nanoparticles
By Application: (Core Demand Driver vs Emerging Opportunity)
Preclinical
Clinical
Commercial
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Precision NanoSystems in Europe)
- Emerging Product Trends: Liposomes adoption vs. Lipid Nanoparticles premiumization
- Demand-Side Dynamics: Preclinical growth in China vs. Clinical potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Liposome Development Service market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Lipid Nanoparticles in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinical in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Liposome Development Service value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Liposomes
1.2.3 Lipid Nanoparticles
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Preclinical
1.3.3 Clinical
1.3.4 Commercial
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liposome Development Service Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Liposome Development Service Revenue Market Share by Region (2020-2025)
2.4 Global Liposome Development Service Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Liposome Development Service Market Size and Prospective (2020-2031)
2.5.2 Europe Liposome Development Service Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Liposome Development Service Market Size and Prospective (2020-2031)
2.5.4 Latin America Liposome Development Service Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa Liposome Development Service Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Liposome Development Service Historic Market Size by Type (2020-2025)
3.2 Global Liposome Development Service Forecasted Market Size by Type (2026-2031)
3.3 Different Types Liposome Development Service Representative Players
4 Breakdown Data by Application
4.1 Global Liposome Development Service Historic Market Size by Application (2020-2025)
4.2 Global Liposome Development Service Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Liposome Development Service Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Liposome Development Service Players by Revenue (2020-2025)
5.1.2 Global Liposome Development Service Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Liposome Development Service Revenue
5.4 Global Liposome Development Service Market Concentration Analysis
5.4.1 Global Liposome Development Service Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Liposome Development Service Revenue in 2024
5.5 Global Key Players of Liposome Development Service Head office and Area Served
5.6 Global Key Players of Liposome Development Service, Product and Application
5.7 Global Key Players of Liposome Development Service, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Liposome Development Service Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Liposome Development Service Market Size by Type (2020-2025)
6.1.2.2 North America Liposome Development Service Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Liposome Development Service Market Size by Application (2020-2025)
6.1.3.2 North America Liposome Development Service Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Liposome Development Service Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Liposome Development Service Market Size by Type (2020-2025)
6.2.2.2 Europe Liposome Development Service Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Liposome Development Service Market Size by Application (2020-2025)
6.2.3.2 Europe Liposome Development Service Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Liposome Development Service Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Liposome Development Service Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Liposome Development Service Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Liposome Development Service Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific Liposome Development Service Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America Liposome Development Service Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Liposome Development Service Market Size by Type (2020-2025)
6.4.2.2 Latin America Liposome Development Service Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Liposome Development Service Market Size by Application (2020-2025)
6.4.3.2 Latin America Liposome Development Service Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa Liposome Development Service Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Liposome Development Service Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa Liposome Development Service Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Liposome Development Service Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa Liposome Development Service Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 Precision NanoSystems
7.1.1 Precision NanoSystems Company Details
7.1.2 Precision NanoSystems Business Overview
7.1.3 Precision NanoSystems Liposome Development Service Introduction
7.1.4 Precision NanoSystems Revenue in Liposome Development Service Business (2020-2025)
7.1.5 Precision NanoSystems Recent Development
7.2 Evonik
7.2.1 Evonik Company Details
7.2.2 Evonik Business Overview
7.2.3 Evonik Liposome Development Service Introduction
7.2.4 Evonik Revenue in Liposome Development Service Business (2020-2025)
7.2.5 Evonik Recent Development
7.3 Merck KGaA
7.3.1 Merck KGaA Company Details
7.3.2 Merck KGaA Business Overview
7.3.3 Merck KGaA Liposome Development Service Introduction
7.3.4 Merck KGaA Revenue in Liposome Development Service Business (2020-2025)
7.3.5 Merck KGaA Recent Development
7.4 Genevant Sciences
7.4.1 Genevant Sciences Company Details
7.4.2 Genevant Sciences Business Overview
7.4.3 Genevant Sciences Liposome Development Service Introduction
7.4.4 Genevant Sciences Revenue in Liposome Development Service Business (2020-2025)
7.4.5 Genevant Sciences Recent Development
7.5 Exelead
7.5.1 Exelead Company Details
7.5.2 Exelead Business Overview
7.5.3 Exelead Liposome Development Service Introduction
7.5.4 Exelead Revenue in Liposome Development Service Business (2020-2025)
7.5.5 Exelead Recent Development
7.6 Avanti Polar Lipids
7.6.1 Avanti Polar Lipids Company Details
7.6.2 Avanti Polar Lipids Business Overview
7.6.3 Avanti Polar Lipids Liposome Development Service Introduction
7.6.4 Avanti Polar Lipids Revenue in Liposome Development Service Business (2020-2025)
7.6.5 Avanti Polar Lipids Recent Development
7.7 Nippon Fine Chemical
7.7.1 Nippon Fine Chemical Company Details
7.7.2 Nippon Fine Chemical Business Overview
7.7.3 Nippon Fine Chemical Liposome Development Service Introduction
7.7.4 Nippon Fine Chemical Revenue in Liposome Development Service Business (2020-2025)
7.7.5 Nippon Fine Chemical Recent Development
7.8 Lipoid
7.8.1 Lipoid Company Details
7.8.2 Lipoid Business Overview
7.8.3 Lipoid Liposome Development Service Introduction
7.8.4 Lipoid Revenue in Liposome Development Service Business (2020-2025)
7.8.5 Lipoid Recent Development
7.9 Polymun Scientific
7.9.1 Polymun Scientific Company Details
7.9.2 Polymun Scientific Business Overview
7.9.3 Polymun Scientific Liposome Development Service Introduction
7.9.4 Polymun Scientific Revenue in Liposome Development Service Business (2020-2025)
7.9.5 Polymun Scientific Recent Development
7.10 Corden Pharma
7.10.1 Corden Pharma Company Details
7.10.2 Corden Pharma Business Overview
7.10.3 Corden Pharma Liposome Development Service Introduction
7.10.4 Corden Pharma Revenue in Liposome Development Service Business (2020-2025)
7.10.5 Corden Pharma Recent Development
7.11 Acuitas Therapeutics
7.11.1 Acuitas Therapeutics Company Details
7.11.2 Acuitas Therapeutics Business Overview
7.11.3 Acuitas Therapeutics Liposome Development Service Introduction
7.11.4 Acuitas Therapeutics Revenue in Liposome Development Service Business (2020-2025)
7.11.5 Acuitas Therapeutics Recent Development
7.12 Creative Biolabs
7.12.1 Creative Biolabs Company Details
7.12.2 Creative Biolabs Business Overview
7.12.3 Creative Biolabs Liposome Development Service Introduction
7.12.4 Creative Biolabs Revenue in Liposome Development Service Business (2020-2025)
7.12.5 Creative Biolabs Recent Development
7.13 Creative Biostructure
7.13.1 Creative Biostructure Company Details
7.13.2 Creative Biostructure Business Overview
7.13.3 Creative Biostructure Liposome Development Service Introduction
7.13.4 Creative Biostructure Revenue in Liposome Development Service Business (2020-2025)
7.13.5 Creative Biostructure Recent Development
7.14 T&T Scientific
7.14.1 T&T Scientific Company Details
7.14.2 T&T Scientific Business Overview
7.14.3 T&T Scientific Liposome Development Service Introduction
7.14.4 T&T Scientific Revenue in Liposome Development Service Business (2020-2025)
7.14.5 T&T Scientific Recent Development
7.15 FormuMax Scientific
7.15.1 FormuMax Scientific Company Details
7.15.2 FormuMax Scientific Business Overview
7.15.3 FormuMax Scientific Liposome Development Service Introduction
7.15.4 FormuMax Scientific Revenue in Liposome Development Service Business (2020-2025)
7.15.5 FormuMax Scientific Recent Development
7.16 PlantaCorp
7.16.1 PlantaCorp Company Details
7.16.2 PlantaCorp Business Overview
7.16.3 PlantaCorp Liposome Development Service Introduction
7.16.4 PlantaCorp Revenue in Liposome Development Service Business (2020-2025)
7.16.5 PlantaCorp Recent Development
7.17 CD Bioparticles
7.17.1 CD Bioparticles Company Details
7.17.2 CD Bioparticles Business Overview
7.17.3 CD Bioparticles Liposome Development Service Introduction
7.17.4 CD Bioparticles Revenue in Liposome Development Service Business (2020-2025)
7.17.5 CD Bioparticles Recent Development
8 Liposome Development Service Market Dynamics
8.1 Liposome Development Service Industry Trends
8.2 Liposome Development Service Market Drivers
8.3 Liposome Development Service Market Challenges
8.4 Liposome Development Service Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Liposome Development Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Liposome Development Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Liposome Development Service Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Liposome Development Service Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Liposome Development Service Revenue Share by Region (2020-2025)
Table 6. Global Liposome Development Service Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Liposome Development Service Revenue Share Forecast by Region (2026-2031)
Table 8. Global Liposome Development Service Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Liposome Development Service Revenue Market Share by Type (2020-2025)
Table 10. Global Liposome Development Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Liposome Development Service Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Liposome Development Service Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Liposome Development Service Revenue Market Share by Application (2020-2025)
Table 15. Global Liposome Development Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Liposome Development Service Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Liposome Development Service Application
Table 18. Global Liposome Development Service Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Liposome Development Service Market Share by Players (2020-2025)
Table 20. Global Top Liposome Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Development Service as of 2024)
Table 21. Ranking of Global Top Liposome Development Service Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Liposome Development Service Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Liposome Development Service, Headquarters and Area Served
Table 24. Global Key Players of Liposome Development Service, Product and Application
Table 25. Global Key Players of Liposome Development Service, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Liposome Development Service Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Liposome Development Service Revenue Market Share by Company (2020-2025)
Table 29. North America Liposome Development Service Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Liposome Development Service Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Liposome Development Service Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Liposome Development Service Revenue Market Share by Company (2020-2025)
Table 33. Europe Liposome Development Service Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Liposome Development Service Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia-Pacific Liposome Development Service Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia-Pacific Liposome Development Service Revenue Market Share by Company (2020-2025)
Table 37. Asia-Pacific Liposome Development Service Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia-Pacific Liposome Development Service Market Size by Application (2020-2025) & (US$ Million)
Table 39. Latin America Liposome Development Service Revenue by Company (2020-2025) & (US$ Million)
Table 40. Latin America Liposome Development Service Revenue Market Share by Company (2020-2025)
Table 41. Latin America Liposome Development Service Market Size by Type (2020-2025) & (US$ Million)
Table 42. Latin America Liposome Development Service Market Size by Application (2020-2025) & (US$ Million)
Table 43. Middle East & Africa Liposome Development Service Revenue by Company (2020-2025) & (US$ Million)
Table 44. Middle East & Africa Liposome Development Service Revenue Market Share by Company (2020-2025)
Table 45. Middle East & Africa Liposome Development Service Market Size by Type (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Liposome Development Service Market Size by Application (2020-2025) & (US$ Million)
Table 47. Precision NanoSystems Company Details
Table 48. Precision NanoSystems Business Overview
Table 49. Precision NanoSystems Liposome Development Service Product
Table 50. Precision NanoSystems Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 51. Precision NanoSystems Recent Development
Table 52. Evonik Company Details
Table 53. Evonik Business Overview
Table 54. Evonik Liposome Development Service Product
Table 55. Evonik Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 56. Evonik Recent Development
Table 57. Merck KGaA Company Details
Table 58. Merck KGaA Business Overview
Table 59. Merck KGaA Liposome Development Service Product
Table 60. Merck KGaA Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 61. Merck KGaA Recent Development
Table 62. Genevant Sciences Company Details
Table 63. Genevant Sciences Business Overview
Table 64. Genevant Sciences Liposome Development Service Product
Table 65. Genevant Sciences Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 66. Genevant Sciences Recent Development
Table 67. Exelead Company Details
Table 68. Exelead Business Overview
Table 69. Exelead Liposome Development Service Product
Table 70. Exelead Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 71. Exelead Recent Development
Table 72. Avanti Polar Lipids Company Details
Table 73. Avanti Polar Lipids Business Overview
Table 74. Avanti Polar Lipids Liposome Development Service Product
Table 75. Avanti Polar Lipids Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 76. Avanti Polar Lipids Recent Development
Table 77. Nippon Fine Chemical Company Details
Table 78. Nippon Fine Chemical Business Overview
Table 79. Nippon Fine Chemical Liposome Development Service Product
Table 80. Nippon Fine Chemical Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 81. Nippon Fine Chemical Recent Development
Table 82. Lipoid Company Details
Table 83. Lipoid Business Overview
Table 84. Lipoid Liposome Development Service Product
Table 85. Lipoid Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 86. Lipoid Recent Development
Table 87. Polymun Scientific Company Details
Table 88. Polymun Scientific Business Overview
Table 89. Polymun Scientific Liposome Development Service Product
Table 90. Polymun Scientific Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 91. Polymun Scientific Recent Development
Table 92. Corden Pharma Company Details
Table 93. Corden Pharma Business Overview
Table 94. Corden Pharma Liposome Development Service Product
Table 95. Corden Pharma Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 96. Corden Pharma Recent Development
Table 97. Acuitas Therapeutics Company Details
Table 98. Acuitas Therapeutics Business Overview
Table 99. Acuitas Therapeutics Liposome Development Service Product
Table 100. Acuitas Therapeutics Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 101. Acuitas Therapeutics Recent Development
Table 102. Creative Biolabs Company Details
Table 103. Creative Biolabs Business Overview
Table 104. Creative Biolabs Liposome Development Service Product
Table 105. Creative Biolabs Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 106. Creative Biolabs Recent Development
Table 107. Creative Biostructure Company Details
Table 108. Creative Biostructure Business Overview
Table 109. Creative Biostructure Liposome Development Service Product
Table 110. Creative Biostructure Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 111. Creative Biostructure Recent Development
Table 112. T&T Scientific Company Details
Table 113. T&T Scientific Business Overview
Table 114. T&T Scientific Liposome Development Service Product
Table 115. T&T Scientific Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 116. T&T Scientific Recent Development
Table 117. FormuMax Scientific Company Details
Table 118. FormuMax Scientific Business Overview
Table 119. FormuMax Scientific Liposome Development Service Product
Table 120. FormuMax Scientific Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 121. FormuMax Scientific Recent Development
Table 122. PlantaCorp Company Details
Table 123. PlantaCorp Business Overview
Table 124. PlantaCorp Liposome Development Service Product
Table 125. PlantaCorp Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 126. PlantaCorp Recent Development
Table 127. CD Bioparticles Company Details
Table 128. CD Bioparticles Business Overview
Table 129. CD Bioparticles Liposome Development Service Product
Table 130. CD Bioparticles Revenue in Liposome Development Service Business (2020-2025) & (US$ Million)
Table 131. CD Bioparticles Recent Development
Table 132. Liposome Development Service Market Trends
Table 133. Liposome Development Service Market Drivers
Table 134. Liposome Development Service Market Challenges
Table 135. Liposome Development Service Market Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposome Development Service Product Picture
Figure 2. Global Liposome Development Service Market Share by Type: 2024 VS 2031
Figure 3. Liposomes Features
Figure 4. Lipid Nanoparticles Features
Figure 5. Global Liposome Development Service Market Share by Application: 2024 VS 2031
Figure 6. Preclinical
Figure 7. Clinical
Figure 8. Commercial
Figure 9. Liposome Development Service Report Years Considered
Figure 10. Global Liposome Development Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Liposome Development Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Liposome Development Service Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Liposome Development Service Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Liposome Development Service Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Asia-Pacific Liposome Development Service Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Latin America Liposome Development Service Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Middle East & Africa Liposome Development Service Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Liposome Development Service Market Share by Players in 2024
Figure 19. Global Top Liposome Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Development Service as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Liposome Development Service Revenue in 2024
Figure 21. North America Liposome Development Service Market Share by Type (2020-2025)
Figure 22. North America Liposome Development Service Market Share by Application (2020-2025)
Figure 23. Europe Liposome Development Service Market Share by Type (2020-2025)
Figure 24. Europe Liposome Development Service Market Share by Application (2020-2025)
Figure 25. Asia-Pacific Liposome Development Service Market Share by Type (2020-2025)
Figure 26. Asia-Pacific Liposome Development Service Market Share by Application (2020-2025)
Figure 27. Latin America Liposome Development Service Market Share by Type (2020-2025)
Figure 28. Latin America Liposome Development Service Market Share by Application (2020-2025)
Figure 29. Middle East & Africa Liposome Development Service Market Share by Type (2020-2025)
Figure 30. Middle East & Africa Liposome Development Service Market Share by Application (2020-2025)
Figure 31. Precision NanoSystems Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 32. Evonik Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 33. Merck KGaA Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 34. Genevant Sciences Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 35. Exelead Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 36. Avanti Polar Lipids Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 37. Nippon Fine Chemical Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 38. Lipoid Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 39. Polymun Scientific Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 40. Corden Pharma Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 41. Acuitas Therapeutics Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 42. Creative Biolabs Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 43. Creative Biostructure Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 44. T&T Scientific Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 45. FormuMax Scientific Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 46. PlantaCorp Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 47. CD Bioparticles Revenue Growth Rate in Liposome Development Service Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
